Neurogenic Blepharoptosis

  • Jonathan W. Kim


Neurogenic blepharoptosis is an important entity to recognize since there are specific considerations in its evaluation and treatment. Most cases are caused by lesions of the oculomotor nerve or a disruption of the oculosympathetic pathway. Neurogenic ptosis can be distinguished from involutional blepharoptosis by the associated findings of pupillary and/or ocular motility abnormalities. The etiology and localization of the lesion is determined by a careful review of the history, associated signs and symptoms, and appropriate neuroimaging studies. The initial treatment approach is aimed at correcting the underlying pathologic process. For patients who require surgical repair of the ptosis, frontalis sling is the only viable option for patients with oculomotor nerve palsy, while both levator resection and Müllerectomy are effective procedures for patients with Horner syndrome.


Nerve Palsy Cavernous Sinus Oculomotor Nerve Levator Muscle Pharmacologic Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Caplan LR. Cerebral ptosis. J Neurol Neurosurg Psychiatry. 1974;34:1–7.CrossRefGoogle Scholar
  2. 2.
    Averbuch-Heller L, Leigh RJ, Mermelstein V, Zagalsky L, Streifler JY. Ptosis in patients with hemispheric strokes. Neurology. 2002;58:620–4.PubMedGoogle Scholar
  3. 3.
    Krohel GB, Griffin JF. Cortical blepharoptosis. Am J Ophthalmol. 1978;85:632–4.PubMedGoogle Scholar
  4. 4.
    Boghen D. Apraxia of eyelid opening: a review. Neurology. 1997;48:1491–4.PubMedGoogle Scholar
  5. 5.
    Lepore FE, Duvoisin RC. “Apraxia” of eyelid opening: an involuntary levator inhibition. Neurology. 1985;35:423–7.PubMedGoogle Scholar
  6. 6.
    Jordan DR, Anderson Rl, Digre K. Apraxia of lid opening in blepharospasm. Ophthalmic Surg. 1990;21:331–4.PubMedGoogle Scholar
  7. 7.
    Richards BW, Jones FR, Younge BR. Causes and prognosis in 4278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489–96.PubMedGoogle Scholar
  8. 8.
    Carter SR, Meecham WJ, Seiff SR. Silicone frontalis slings for the correction of blepharoptosis: indications­ and efficacy. Ophthalmology. 1996;103(4):623–30.PubMedGoogle Scholar
  9. 9.
    Kardon RH, Denison CE, Brown CK, Thompson HS. Critical evaluation of the cocaine test in the diagnosis of Horner’s syndrome. Arch Ophthalmol. 1990;108:384–7.PubMedGoogle Scholar
  10. 10.
    Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol. 2005;89(11):1442–4.CrossRefPubMedGoogle Scholar
  11. 11.
    Brown SM, Aouchiche R, Freedman KA. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Arch Ophthalmol. 2003;121(8):1201–3.CrossRefPubMedGoogle Scholar
  12. 12.
    Morales J, Brown SM, Abdul-Rahim AS, Crosson CE. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol. 2000;118:951–4.PubMedGoogle Scholar
  13. 13.
    Cremer SA, Thompson HS, Digre KB, Kardon RH. Hydroxyamphetamine mydriasis in Horner’s syndrome. Am J Ophthalmol. 1990;110:71–6.PubMedGoogle Scholar
  14. 14.
    Maloney WF, Younge BR, Moyer NK. Evaluation of the causes and accuracy of pharmacologic location of Horner’s syndrome. Am J Ophthalmol. 1980;90:394–402.PubMedGoogle Scholar
  15. 15.
    Kline LB, Vitek JJ, Raymon BC. Painful Horner’s syndrome due to spontaneous carotid artery dissection. Ophthalmology. 1987;94:226–30.PubMedGoogle Scholar
  16. 16.
    Jeffery AR, Ellis FJ, Repka MX, Buncic JR. Pediatric Horner syndrome. J AAPOS. 1998;2:159–67.CrossRefPubMedGoogle Scholar
  17. 17.
    Watts P, Satterfirld D, Lim MK. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. J AAPOS. 2007;11(3):282–3.CrossRefPubMedGoogle Scholar
  18. 18.
    George ND, Gonzalez G, Hoyt CS. Does Horner’s syndrome in infancy require investigation? Br J Ophthalmol. 1998;82:51–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Musarella MA, Chan HS, DeBoer G, Gallie BL. Ocular involvement in neuroblastoma: prognostic implications. Ophthalmology. 1984;91:936–40.PubMedGoogle Scholar
  20. 20.
    Mahoney NR, Liu GT, Menacker SJ, Wilson MC, Hogarty MD, Maris JM. Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions. Am J Ophthalmol. 2006;142:651–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Glatt HJ, Putterman AM, Fett DR. Müller’s muscle-conjunctival resection procedure in the treatment of ptosis in Horner’s syndrome. Ophthalmic Surg. 1990;21(2):93–6.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of OphthalmologyStanford Medical CenterStanfordUSA

Personalised recommendations